Jennifer Weiszmann
Amgen (United States)(US)Discovery Centre(CA)
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Kruppel-like factors research, Epigenetics and DNA Methylation, Receptor Mechanisms and Signaling, Peroxisome Proliferator-Activated Receptors
Most-Cited Works
- → Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids(2008)465 cited
- → T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities(2002)319 cited
- → Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex(2012)211 cited
- → FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation(2009)177 cited
- → Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2(2008)154 cited
- → Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling(2007)138 cited
- → Elucidation of signaling and functional activities of an orphan GPCR, GPR81(2008)119 cited
- → INT131: A Selective Modulator of PPARγ(2009)116 cited
- → A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys(2017)104 cited
- → Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice(2009)104 cited